Brandon D. Smith

Insider Reports History

Entity
Individual
Location
C/O Impel Pharmaceuticals Inc., 201 Elliott Avenue West, Suite 260, Seattle, WA
Signature
/s/ Brandon D. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Insider Reports Filed by Brandon D. Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMPL IMPEL PHARMACEUTICALS INC Dec 18, 2023 0 $0 3 Dec 26, 2023 Chief Restructuring Officer